Showing results (1591-1600 of 2,860) with videos related to

Sort By:
Pageof 286
Neuropsychobiology|November 13, 2004
Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patientsMatthias Vogel, Silvia Pfeifer, Rainer T Schaub, et al.
Neuropsychobiology|November 13, 2004
MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and ravesA C Parrott
Neuropsychobiology|January 1, 1979
Knowledge and technology needed for further development of mental health programmesV N Bagadia, L Eisenberg, M O Olatawura, et al.
Neuropsychobiology|June 9, 2005
Ghrelin plasma levels during psychopharmacological treatmentHubertus Himmerich, Stephany Fulda, Heike E Künzel, et al.
Neuropsychobiology|June 9, 2005
Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation studyL Janiri, G Martinotti, T Dario, et al.
Neuropsychobiology|May 5, 2005
Relationship between class I and II HLA antigens in schizophrenia and eye movement disturbances: a preliminary studyPrzemysław A Bogacki, Alina Borkowska, Małgorzata Wojtanowska-Bogacka, et al.
Neuropsychobiology|July 2, 2005
Functional polymorphism of the glutathione peroxidase 1 gene is associated with personality traits in healthy subjectsDaisuke Matsuzawa, Kenji Hashimoto, Eiji Shimizu, et al.
Neuropsychobiology|July 2, 2005
Influence of age, gender, health status, and depression on quantitative EEGMelinda L Morgan, Elise A Witte, Ian A Cook, et al.
Neuropsychobiology|January 5, 2023
Intranasal Oxytocin as Add-On Treatment for Inpatients with Severe Mental Illness: A Randomized Clinical TrialAriella Grossman-Giron, Hagai Maoz, Uri Nitzan, et al.
Neuropsychobiology|January 9, 2023
Treatment Resistance in Schizophrenia Is Associated with Attention Deficit/Hyperactivity Disorder and Gut Microbiota: A Genetic Correlation and Mendelian Randomization StudyBolun Cheng, Shiqiang Cheng, Chun'e Li, et al.
Pageof 286